The relatively recent submissions by state policymakers requesting to close their Medicaid formularies highlighted ethical concerns regarding access and treatment of patients who are poor or vulnerable.
Americans could import less expensive prescription drugs from Canada under a plan being developed by the Trump administration.
The enactment of medical marijuana laws in the United States was not found to be associated with a reduction in the use of nonmedical prescription opioids or in prescription opioid use disorder.
An estimated 20 million people in the United States meet the criteria for substance use disorder.
The Mayo Clinic has instituted a Patient and Visitor Conduct Policy that balances the dual needs of providing optimal patient care while maintaining a supportive, respectful workplace for staff.
The 11th edition of the International Classification of Diseases includes chronic pain in the “Symptoms, Signs or Clinical Findings” category.
Policies requiring prior authorization for high-dose opioid prescriptions were found to be effective in reducing the average daily opioid dose consumed.
Millions of workers gained insurance coverage under the Affordable Care Act (ACA) without adverse effects on labor markets.
The American Heart Association and others are urging the court to reconsider changes to short-term limited-duration insurance plans.
According to an article published in Headache, the US Food and Drug Administration (FDA) was aware of safety issues associated with the Zecuity transdermal patch for migraine prior to its approval.
